Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FK885
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,816
Award facts
- Contract value 100% obligated
- $48,816.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $48,816.00 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on January 8, 2026, with an ultimate completion date of January 9, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the comprehensive vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Zepbound, a GLP-1 receptor agonist indicated for chronic weight management, represents part of the federal government's pharmaceutical procurement for military treatment facilities and related defense healthcare systems. The short timeline between award and completion dates suggests this delivery order fulfills an urgent medical supply requirement within the existing DLA pharmaceutical prime vendor framework. AmerisourceBergen's extensive federal contracting history and competitive positioning within the defense pharmaceutical supply chain demonstrate its established capability to meet government medical procurement needs across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FK885?
SPE2DR26FK885 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FK885 worth?
The government has obligated $48,816 on SPE2DR26FK885.
Is contract SPE2DR26FK885 an order under another contract?
Yes. SPE2DR26FK885 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK885 competed?
The extent of competition for SPE2DR26FK885 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award